Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
Funding providers: Swansea University Strategic Partnership Research Scholarships (SUSPRS) with Université Grenoble Alpes, France Subject areas: Biomechanics, Biomedical Engineering, Computational
-
engineering to generate required reporter lines - and perform mass-spectrometry proteomics to identify phosphorylation patterns and binding partners of the cryptochromes. You will work closely others in
-
engineering to generate required reporter lines - and perform mass-spectrometry proteomics to identify phosphorylation patterns and binding partners of the cryptochromes. You will work closely others in
-
The University of Nottingham’s Digital Research Service (DRS) is looking for a trained Data Scientist/Engineer with interest in working with Biological and Biomaterials data. The DRS is a dedicated
-
. This research position will evaluate disruption in sensory neural tissue integrity and function through investigating chemotherapy induced inflammation and metabolic disturbance to understand the cause of pain in
-
Department: School of Engineering and Materials Science Salary: £40,223 - £42,405 per annum (Grade 4) Reference: 2616 Location: Mile End Date posted: 12 June 2024 Closing date: 27 June 2024 Further
-
of this approach through the use of 3D in vitro models. This position is based in the School of Engineering & Materials Science, home to QMULs Centre for Bioengineering. The School has an international award
-
this scale is subject to performance. Closing Date: Tuesday 09 July 2024 Reference: DTS219624 The University of Nottingham’s Digital Research Service (DRS) is looking for a trained Data Scientist/Engineer
-
. Strong interest in chromatin biology and/or gene regulation is crucial whilst previous experience in molecular biology, genome-engineering and 3C/Hi-C techniques are desirable. The Opportunity
-
cytometers (Attune NxT, CytoFlex LX), advanced omics technologies (FlexMap3D, ChromiumX (10X)), and high-performance data analysis structure. This portfolio has been expanded by further state-of-the-art Tissue